• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Starpharma Holdings Ltd

+ Add to Watchlist


0.7700 AUD 0.0200 2.53%

As of 02:10:35 ET on 04/16/2014.

Snapshot for Starpharma Holdings Ltd (SPL)

Open: 0.7950 Day's Range: 0.7700 - 0.7950 Volume: 207,160
Previous Close: 0.7900 52wk Range: 0.6450 - 1.1500 1-Yr Rtn: -28.37%

Stock Chart for SPL

No chart data available.
  • SPL:AU 0.7700
  • 1D
  • 1M
  • 1Y
Interactive SPL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SPL

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0316
Est. EPS (AUD) (06/2014) -0.0380
Est. PEG Ratio -
Market Cap (M AUD) 219.19
Shares Outstanding (M) 284.66
30 Day Average Volume 512,187
Price/Book (mrq) 5.3021
Price/Sale (ttm) 353.6064
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/26/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SPL

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for SPL

Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.

Robert Bain Thomas "Rob"ChairmanJacinth K Fairley "Jackie"CEO/Executive Director
Nigel J BaadeCFO/SecretaryTony EglezosVP:Business Development
More Company Profile & Key Executives for SPL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil